• Publications
  • Influence
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.
TLDR
This guideline process was based on a literature review through 1 June 2009 using MEDLINE and other databases and believes that this is the most representative and evidence-based guideline process that has yet been performed.
The prevalence of psychiatric disorders among cancer patients.
TLDR
Two hundred fifteen randomly accessed cancer patients who were new admissions to three collaborating cancer centers were examined for the presence of formal psychiatric disorder, and the large majority of conditions were judged to represent highly treatable disorders.
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.
TLDR
Goals related to the complete control of emesis, ie, no vomiting, include providing care that is convenient for the patient, treatment that reduces hospitalization and time in the ambulatory setting, and therapy that enhances the patient’s quality of life.
Cancer-related fatigue: the scale of the problem.
TLDR
The prevalence of cancer-related fatigue is examined and the impact of this distressing symptom on patients' functioning and QoL is explored.
Mechanisms of cancer-related fatigue.
TLDR
The mechanisms that lead to fatigue in conditions in which fatigue is a characteristic provide a theoretical basis for future research into the complex etiology of this distressing and debilitating symptom.
Prevalence of complementary and alternative medicine use in cancer patients during treatment
TLDR
An overwhelming proportion of cancer patients are using CAM, particularly prayer, relaxation, and exercise, but patients may not discuss the use of CAMs at all or fully with their physician; if they do, it is most likely to be their oncologist, but not about the most frequently used CAMs.
Prevalence, mechanisms, and management of cancer-related cognitive impairment
TLDR
This review highlights key research being conducted in these areas, both in patient populations and in animals, which will ultimately result in better understanding and effective treatments for CRCI.
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.
TLDR
The proportions of patients with cancer in this sample reporting symptoms of insomnia and meeting diagnostic criteria for insomnia syndrome during chemotherapy are approximately three times higher than the proportions reported in the general population.
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
TLDR
The Update Committee noted the importance of continued symptom monitoring throughout therapy, and Clinicians underestimate the incidence of nausea, which is not as well controlled as emesis.
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
TLDR
The Update Committee no longer recommends the combination of a 5-HT3 serotonin receptor antagonist and dexamethasone for the prevention of delayed emesis after chemotherapeutic agents of high emetic risk.
...
1
2
3
4
5
...